335 related articles for article (PubMed ID: 18823813)
1. Plasma amantadine concentrations in patients with Parkinson's disease.
Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
[TBL] [Abstract][Full Text] [Related]
2. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
[TBL] [Abstract][Full Text] [Related]
3. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
[TBL] [Abstract][Full Text] [Related]
4. Features associated with the development of hallucinations in Parkinson's disease.
Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
[TBL] [Abstract][Full Text] [Related]
5. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
[No Abstract] [Full Text] [Related]
6. Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.
Yeh HH; Yang YH; Chen SH
Electrophoresis; 2010 Jun; 31(11):1903-11. PubMed ID: 20446294
[TBL] [Abstract][Full Text] [Related]
7. Amantadine in Parkinson's disease: pro and contra.
Greulich W; Fenger E
J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
[TBL] [Abstract][Full Text] [Related]
8. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
Kubo S; Iwatake A; Ebihara N; Murakami A; Hattori N
Parkinsonism Relat Disord; 2008; 14(2):166-9. PubMed ID: 17509924
[TBL] [Abstract][Full Text] [Related]
9. An artist's view of drug-induced hallucinosis.
Ebersbach G
Mov Disord; 2003 Jul; 18(7):833-4. PubMed ID: 12815666
[TBL] [Abstract][Full Text] [Related]
10. Dropped head associated with amantadine in Parkinson disease.
Kataoka H; Ueno S
Clin Neuropharmacol; 2011; 34(1):48-9. PubMed ID: 21242745
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
12. Amantadine-induced livedo reticularis: a report of two cases.
Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
[TBL] [Abstract][Full Text] [Related]
13. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Postma JU; Van Tilburg W
J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
[TBL] [Abstract][Full Text] [Related]
14. Amantadine induced reversible corneal edema.
Deogaonkar M; Wilson K; Vitek J
J Clin Neurosci; 2011 Feb; 18(2):298-9. PubMed ID: 21163653
[TBL] [Abstract][Full Text] [Related]
15. Association between amantadine and the onset of dementia in Parkinson's disease.
Inzelberg R; Bonuccelli U; Schechtman E; Miniowich A; Strugatsky R; Ceravolo R; Logi C; Rossi C; Klein C; Rabey JM
Mov Disord; 2006 Sep; 21(9):1375-9. PubMed ID: 16705684
[TBL] [Abstract][Full Text] [Related]
16. Amantadine and other antiglutamate agents: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
[No Abstract] [Full Text] [Related]
17. Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients.
Müller T; Kuhn W; Quack G; Przuntek H
J Neural Transm Suppl; 1995; 46():407-13. PubMed ID: 8821076
[TBL] [Abstract][Full Text] [Related]
18. Trial of amantadine in Parkinson's disease.
Campbell AM; Williams MJ
Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
[No Abstract] [Full Text] [Related]
19. Amantadine-induced "vocal" myoclonus.
Pfeiffer RF
Mov Disord; 1996 Jan; 11(1):104-6. PubMed ID: 8771080
[No Abstract] [Full Text] [Related]
20. Memantine-induced myoclonus and delirium exacerbated by trimethoprim.
Moellentin D; Picone C; Leadbetter E
Ann Pharmacother; 2008 Mar; 42(3):443-7. PubMed ID: 18303133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]